Alfacell Corp (NASDAQOTH:ACEL.PK)
CAPS Rating:
A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.
RSS Headlines
Fool UK